STAT

STAT+: Pharmalittle: Sanofi R&D head unexpectedly steps down; U.K. tax rate criticized after AstraZeneca locates plant in Ireland

Sanofi says its global head of research and development, John Reed, is stepping down after shareholders criticized its development pipeline.
Source: Alex Hogan/STAT

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so familiar routine of online

You’re reading a preview, subscribe to read more.

More from STAT

STAT1 min read
Opinion: STAT+: Unmasking The ‘Centricity’ Illusion In Clinical Trials
The glacial pace of change in mechanistic but essential areas of clinical trials undermines the biopharma industry's claims of progress and compassion.
STAT1 min read
STAT+: Pharmalittle: We’re Watching A Cytokinetics Deal With Royalty Pharma, Cue Health Shutting Down, And More
Cytokinetics did a deal with Royalty Pharma, the biotech firm that has become a huge success by buying up small shares of other companies’ drugs.
STAT1 min read
STAT+: Wearable Devices Generate Powerful Data But It’s Not Useful To Doctors, Yet
Data from wearables can be powerful but they're not useful to doctors yet, experts said at the #STATBreakthrough Summit in San Francisco.

Related Books & Audiobooks